Nutex Health EBITDA Margin 2016-2024 | NUTX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Nutex Health (NUTX) over the last 10 years. The current EBITDA margin for Nutex Health as of September 30, 2024 is .
| Nutex Health EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-09-30 | $0.29B | $0.01B | 3.42% |
| 2024-06-30 | $0.28B | $-0.00B | -0.36% |
| 2024-03-31 | $0.26B | $-0.01B | -2.70% |
| 2023-12-31 | $0.25B | $-0.01B | -5.24% |
| 2023-09-30 | $0.23B | $0.01B | 2.16% |
| 2023-06-30 | $0.20B | $-0.42B | -214.72% |
| 2023-03-31 | $0.20B | $-0.43B | -216.84% |
| 2022-12-31 | $0.22B | $-0.39B | -179.45% |
| 2022-09-30 | $0.31B | $-0.32B | -100.64% |
| 2022-06-30 | $0.40B | $0.18B | 45.54% |
| 2022-03-31 | $0.41B | $0.21B | 52.32% |
| 2021-12-31 | $0.33B | $0.18B | 53.61% |
| 2021-09-30 | $0.46B | $0.26B | 57.24% |
| 2021-06-30 | $0.34B | $0.19B | 55.33% |
| 2021-03-31 | $0.28B | $0.16B | 56.73% |
| 2020-12-31 | $0.27B | $0.16B | 58.24% |
| 2020-09-30 | $0.00B | $-0.00B | -100.00% |
| 2020-06-30 | $0.00B | $-0.00B | -400.00% |
| 2020-03-31 | $0.00B | $-0.01B | -600.00% |
| 2019-12-31 | $0.00B | $-0.01B | -600.00% |
| 2019-09-30 | $0.00B | $-0.00B | -300.00% |
| 2019-06-30 | $0.00B | $-0.00B | -200.00% |
| 2019-03-31 | $0.00B | $-0.00B | -100.00% |
| 2018-12-31 | $0.00B | 0 | 0.00% |
| 2018-09-30 | $0.00B | $-0.00B | inf% |
| 2018-06-30 | $0.00B | $-0.00B | inf% |
| 2018-03-31 | $0.00B | $-0.01B | inf% |
| 2017-12-31 | $0.00B | $-0.01B | inf% |
| 2016-03-31 | $0.00B | 0 | nan% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.256B | $0.480B |
| Nutex Health Inc. is a physician-led, technology-enabled healthcare services company. The Company's operating divisions include Hospital division and Population Health Management division. Hospital division implements and operates different health care models, including micro hospitals, specialty hospitals and hospital outpatient departments. Population Health Management division owns and operates provider networks such as Independent Physician Associations. Nutex Health Inc., formerly known as Clinigence Holdings Inc., is based in HOUSTON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $146.516B | 27.37 |
| Elevance Health (ELV) | United States | $98.469B | 13.19 |
| CVS Health (CVS) | United States | $85.419B | 12.50 |
| Cencora (COR) | United States | $53.926B | 19.57 |
| DiDi Global (DIDIY) | China | $23.525B | 0.00 |
| Natera (NTRA) | United States | $19.117B | 0.00 |
| BioMerieux (BMXMF) | France | $14.914B | 0.00 |
| ICON (ICLR) | Ireland | $14.132B | 12.84 |
| Solventum (SOLV) | United States | $13.154B | 12.27 |
| Revvity (RVTY) | United States | $12.712B | 21.59 |
| Avantor (AVTR) | United States | $11.045B | 16.21 |
| CochLear (CHEOY) | Australia | $10.877B | 0.00 |
| Doximity (DOCS) | United States | $10.834B | 56.34 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.609B | 0.00 |
| Viatris (VTRS) | United States | $10.397B | 3.29 |
| Medpace Holdings (MEDP) | United States | $9.283B | 24.12 |
| Sonic Healthcare (SKHHY) | Australia | $7.768B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.697B | 14.59 |
| HealthEquity (HQY) | United States | $7.644B | 37.60 |
| Bausch + Lomb (BLCO) | Canada | $5.111B | 23.39 |
| Amplifon S.p.A (AMFPF) | Italy | $4.961B | 26.19 |
| Organon (OGN) | United States | $3.841B | 3.91 |
| Alignment Healthcare (ALHC) | United States | $3.572B | 0.00 |
| Sotera Health (SHC) | United States | $3.305B | 19.11 |
| BrightSpring Health Services (BTSG) | United States | $3.165B | 32.89 |
| Surgery Partners (SGRY) | United States | $3.031B | 34.93 |
| Concentras Parent (CON) | United States | $2.781B | 14.47 |
| GeneDx Holdings (WGS) | United States | $2.486B | 295.22 |
| Ardent Health Partners (ARDT) | United States | $1.963B | 0.00 |
| Progyny (PGNY) | United States | $1.908B | 42.15 |
| Agilon Health (AGL) | United States | $1.785B | 0.00 |
| Premier (PINC) | United States | $1.760B | 11.27 |
| PACS (PACS) | United States | $1.713B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.692B | 36.75 |
| Teladoc Health (TDOC) | United States | $1.382B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.243B | 10.42 |
| Establishment Labs Holdings (ESTA) | $1.177B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.031B | 0.00 |
| CareDx (CDNA) | United States | $0.984B | 16.75 |
| AMN Healthcare Services Inc (AMN) | United States | $0.934B | 7.39 |
| Embecta (EMBC) | United States | $0.741B | 5.08 |
| QDM (QDMI) | Hong Kong, SAR China | $0.526B | 13.77 |
| Auna S.A (AUNA) | Luxembourg | $0.526B | 13.94 |
| Enhabit (EHAB) | United States | $0.444B | 41.86 |
| Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.403B | 0.00 |
| SBC Medicals (SBC) | United States | $0.329B | 0.00 |
| DocGo (DCGO) | United States | $0.269B | 11.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.265B | 0.00 |
| LifeMD (LFMD) | United States | $0.243B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.232B | 0.00 |
| Beauty Health (SKIN) | United States | $0.168B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.139B | 0.00 |
| So-Young (SY) | China | $0.098B | 0.00 |
| Biodesix (BDSX) | United States | $0.091B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.090B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| Oncology Institute (TOI) | United States | $0.086B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.075B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.056B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.024B | 0.00 |
| ModivCare (MODV) | United States | $0.019B | 6.57 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| KindlyMD (KDLY) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.001B | 0.00 |
| Aclarion (ACON) | United States | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |